With evolving privacy laws and growing consumer demands, collecting and using data responsibly is more critical than ever.

Previously announced data from the phase III READY clinical ... and uphold Galderma’s position at the forefront of aesthetic advancements." ...

Previously announced data from the phase III READY clinical ... Results supported a fast onset of aesthetic improvement at Day 1 (40%; subject-reported) and a duration of effect through 6 months1.

Previously announced data from the phase III READY clinical ... and uphold Galderma’s position at the forefront of aesthetic advancements.” RELAX is a phase IIIb, multicenter, randomized ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset ...

announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aesthetic efficacy, as well as high patient satisfaction and ...

“The Pillars of Confidence data shows how aesthetic treatments enable patients to take an active role in aligning their self-perception with their outward appearance,” said Dr. Shannon ...

“The Pillars of Confidence data shows how aesthetic treatments enable patients to take an active role in aligning their self-perception with their outward appearance,” said Dr. Shannon Humphrey, ...

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the findings of its inaugural global study, Pillars of Confidence: Global Insights on Aesthetics and ...